Patent ID: 11892353
Assignee: SPECLIPSE, INC.
Field: Measurement (Instruments)
Classification: CPC G  A  B  F  Y | IPC B  F  G

Claim 7:
8. A method for providing a medical information using a laser-induced breakdown spectroscopy (LIBS) device, the method comprising:
projecting, by a laser projector, a pulsed beam to a target;
separating, by a spectral member, light generated in connection with a plasma ablation induced at the target by the pulsed beam;
alternately and continuously repeating, by a sensor array, 1) a plurality of exposure periods for accumulating electrical energy according to received light and 2) a plurality of reset periods for initializing the electrical energy accumulated during the exposure period;
generating, by the sensor array, a plurality of a spectrum data, which is related to the plurality of exposure periods, including a plurality of intensity values of the separated light received from the spectral member in predetermined wavelength band;
selecting, by a controller, the target specific exposure period among the plurality of the exposure periods; and
obtaining, by the controller, the spectrum data related to the specific exposure period from the sensor array,
providing, by the controller, diagnostic information on whether the target is related to a disease based on the spectrum data by using an artificial neural network, and
wherein the sensor arrays configured to be set for the exposure period to have a predetermined duration such that the spectrum data includes 1) first spectrum information related to the continuum emission having overall intensity values for the predetermined wavelength band and 2) second spectrum information related to the element specific emission having intensity values of one or more spectral peaks within the predetermined wavelength band.